134 related articles for article (PubMed ID: 1786194)
1. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
Kondo T; Sakamoto J; Nakazato H
Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
[TBL] [Abstract][Full Text] [Related]
2. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Ichihashi H; Kondo T; Nakazato H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
[TBL] [Abstract][Full Text] [Related]
3. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Nakazato H; Ichihashi H; Kondo T
Gan To Kagaku Ryoho; 1986 Feb; 13(2):308-18. PubMed ID: 3947108
[TBL] [Abstract][Full Text] [Related]
4. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
[TBL] [Abstract][Full Text] [Related]
6. [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate].
Ichihashi H; Kondo T; Yamauchi M; Isomatsu T; Nakamura T; Sakabe T; Nakajima T; Ikenaga T; Shiratori T; Taguchi T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):331-6. PubMed ID: 3918509
[TBL] [Abstract][Full Text] [Related]
7. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
[TBL] [Abstract][Full Text] [Related]
8. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
9. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
Imaizumi M; Kondo T; Kamei H; Ichihashi H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
[TBL] [Abstract][Full Text] [Related]
10. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).
Ueda Y; Fujimura T; Kinami S; Hirono Y; Yamaguchi A; Naitoh H; Tani T; Kaji M; Yamagishi H; Miwa K;
Jpn J Clin Oncol; 2006 Aug; 36(8):519-22. PubMed ID: 16803844
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
Tsujitani S; Kakeji Y; Orita H; Watanabe A; Kohnoe S; Baba H; Anai H; Maehara Y; Sugimachi K
Anticancer Res; 1992; 12(3):645-8. PubMed ID: 1622120
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years.
Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
Jpn J Surg; 1988 Nov; 18(6):681-6. PubMed ID: 3150019
[TBL] [Abstract][Full Text] [Related]
14. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondou T; Abe O; Kikuchi K; Tanabe T; Ogawa N
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):799-806. PubMed ID: 2496668
[TBL] [Abstract][Full Text] [Related]
15. [Compound therapy including PSK for malignant head and neck cancer].
Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
[TBL] [Abstract][Full Text] [Related]
16. [A long-surviving case of gastric cancer with peritoneal metastasis (P3) responding to short-term high-dose chemotherapy and long-term immunotherapy].
Kusama M; Kimura K; Suzuki K; Fukaya Y; Saitoh S; Eiraku H; Kawahara S; Ueno M; Kawaguchi M
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3453-6. PubMed ID: 2802638
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on immunochemotherapy (PSK, CQ) in rat bladder cancer (BC-47)].
Nakagami Y; Kishimoto T; Matsumoto K
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1968-74. PubMed ID: 4051512
[TBL] [Abstract][Full Text] [Related]
18. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S; Sakamoto J; Teramukai S; Kunieda K; Sugiyama Y; Ohashi Y; Nakazato H
Surg Today; 1999; 29(6):504-10. PubMed ID: 10385364
[TBL] [Abstract][Full Text] [Related]
19. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1997; 17(4A):2815-8. PubMed ID: 9252721
[TBL] [Abstract][Full Text] [Related]
20. Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma.
Mickey DD
Cancer Chemother Pharmacol; 1985; 15(1):54-8. PubMed ID: 4006049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
